FINA BIOSOLUTIONS
Fina Biosolutions offers bioconjugation, protein expression, purification, immunoassay design, analytics, training, and consulting services.
FINA BIOSOLUTIONS
Industry:
Analytics Biotechnology Consulting Professional Services Training
Founded:
2006-01-01
Address:
Rockville, Maryland, United States
Country:
United States
Website Url:
http://www.finabio.net
Total Employee:
1+
Status:
Active
Contact:
+1 8773462246
Email Addresses:
[email protected]
Official Site Inspections
http://www.finabio.net Semrush global rank: 3.03 M Semrush visits lastest month: 5.34 K
- Host name: cloudproxy10129.sucuri.net
- IP address: 192.124.249.129
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Fina Biosolutions"
Fina Biosolutions 2025 Company Profile: Valuation, …
Information on valuation, funding, cap tables, investors, and executives for Fina Biosolutions. Use the PitchBook Platform to explore the full profile.See details»
Fina Biosolutions - Crunchbase Company Profile
Fina Biosolutions offers bioconjugation, protein expression, purification, immunoassay design, analytics, training, and consulting services.See details»
Fina Biosolutions LLC - selectscience.net
Dr. Andrew Lees founded Fina Biosolutions in 2006 to help emerging market vaccine manufacturers learn to make affordable protein polysaccharide conjugates for vaccines. …See details»
Fina Biosolutions LLC - Drug pipelines, Patents, Clinical trials
Jun 15, 2025 With this acquisition, SK bioscience will become FinaBio's first and sole strategic investor. Continue Reading Korea’s SK bioscience Acquires Stake in U.S. Biotech Fina …See details»
Fina Biosolutions - VentureRadar
Fina Biosolutions LLC is a privately held research and development-stage biotechnology company that discovers, develops, and collaborates to commercialize novel vaccine conjugates for the …See details»
Fina Biosolutions - 2025 Company Profile & Team - Tracxn
Aug 3, 2025 Fina Biosolutions - Biotechnology company specializing in bioconjugation services mainly for vaccine development. Raised a total funding of $3M over 4 rounds from 4 investors.See details»
Fina Biosolutions Profile
Federal contract and grant recipient FINA BIOSOLUTIONS LLC (UEI DV4LJ9BSNXH7, CAGE 4WZ88) is headquartered in Rockville MD. Its primary registered NAICS is 541714 Research …See details»
Conjugate Vaccines Rockville | About Fina Biosolutions
Dr. Andrew Lees founded Fina Biosolutions in 2006 to help emerging market vaccine manufacturers learn to make affordable protein polysaccharide conjugates for vaccines. FinaBio is now a premier provider of conjugate …See details»
Fina Biosolutions Company Profile - Office Locations ... - Craft
Fina Biosolutions has 5 employees at their 1 location. See insights on Fina Biosolutions including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Fina Biosolutions - Products, Competitors, Financials, Employees ...
FinaBio will complete the production of ClickCRM using its proprietary purification and formulation methods for CRM197. FinaBio will be responsible for the marketing and commercialisation of …See details»
Fina Biosolutions LLC - LinkedIn
Fina Biosolutions LLC is a privately held research and development stage biotechnology company that discovers, develops, and collaborates to commercialize novel vaccine conjugates for …See details»
Fina Biosolutions LLC - CMOCRO
Fina Biosolutions LLC is a private, research and development stage biotechnology company that discovers, develops, and collaborates to commercialize novel vaccine conjugates for …See details»
Fina Biosolutions and PATH Contract for Manufacturing …
Nov 15, 2018 ROCKVILLE, Md. – Fina Biosolutions LLC announced today it has reached agreement with PATH, a global organization focused on solving some of the world’s most …See details»
Client Announcement: Congrats Fina Biosolutions!
Oct 16, 2024 SK Bioscience has made public a $3M investment in Fina Biosolutions (FinaBio), a biotechnology company specializing in next-generation conjugate vaccine technology. This …See details»
News - Fina Biosolutions
Fina Biosolutions has selected Scorpius BioManufacturing, a biologics contract development and manufacturing organization (CDMO), for the production of an E.coli-expressed …See details»
Fina Biosolutions Selects Scorpius BioManufacturing for …
Jul 23, 2002 San Antonio, TX (USA) – Fina Biosolutions has selected Scorpius BioManufacturing, a biologics contract development and manufacturing organization (CDMO), …See details»
Fina Biosolutions Selects Scorpius BioManufacturing for …
Jul 27, 2023 Fina Biosolutions has selected Scorpius BioManufacturing, a biologics contract development and manufacturing organization (CDMO), for the production of an E.coli …See details»
News - Page 2 of 4 - Fina Biosolutions
How PATH and FinaBio Make Vaccines Affordable PATH (path.org), an organization promoting health in low income countries, has published an article on their smaller partners, including …See details»
US to retaliate against IMO members that back net zero emissions …
3 days ago The U.S. on Tuesday rejected the Net-Zero Framework proposal by the International Maritime Organization, which is aimed at reducing global greenhouse gas emissions from the …See details»
Intellectual Property - Fina Biosolutions
Aug 24, 2017 Products sold on this website are subject to the following patents: Expression and Purification of CRM197 and Related Proteins JP 7073312. Granted 05/13/2022 KR 10 …See details»